More Good Days video&brief questionnaire
OtherHelp patients with advanced cancer think about what a good day means to them and to help them think about questions they may have for their physicians when discussing treatments
NCT Number: NCT03392090
This research study is evaluating the usefulness of a video and questionnaire to help cancer patients think about the goals of their care.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Dana Farber Cancer Institute, Boston, Massachusetts, United States
The investigators are conducting a study with patients from Dana Farber Cancer Institute (DFCI) and DFCI-affiliate at St. Elizabeth's Hospital who are being treated for their cancer. The purpose of the study is to test the implementation of a short video, a brief questionnaire, and a wallet card designed to help patients understand and articulate their goals and preferences when making decisions about their cancer treatment and communicate these preferences to their clinicians.
The short video and brief questionnaire were developed to help patients with cancer think about their goals of care and their treatment and information preferences and to prompt discussions with their health care team about these preferences. The wallet card is designed to help patients remember some key questions that may be useful as they make decisions about future treatments
A pilot test will be completed to assess the feasibility and usability of the revised "More Good Days" video, brief questionnaire and wallet card in helping seriously-ill cancer patients think about what a good day means to them and test whether these tools can help patients to identify and communicate their medical treatment preferences and goals with their care team.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Help patients with advanced cancer think about what a good day means to them and to help them think about questions they may have for their physicians when discussing treatments
Time frame: 2 years
% of patients invited to participate who choose to enroll
Time frame: 1 month
% who rate intervention as good/very good/excellent.
Time frame: 1 month
% who would recommend intervention to others with cancers like theirs
Time frame: 1 month
preferences for watching alone vs. with family; in clinic vs. home, interest in accessing via electronic record portal
Time frame: 1 month
Hospital Anxiety and Depression Scale (HADS) (score 0 to 21 for 7 anxiety items, higher=more anxiety)
Time frame: 1 month
National Comprehensive Cancer Network distress thermometer (score 0 to 10, higher worse distress)
Time frame: 1 month
Patient Health Questionnaire-9 (PHQ-9) (9 items, score 0 to 27, higher = more depressed)
Time frame: 1 month
Hearth Hope Index (12 items, score 12 to 48, higher = more hope)
Time frame: 1 month
FACIT-PAL instrument general quality of life (27 general items, score 0 to 108, higher=better quality of life)
Time frame: 1 month
Palliative care subscale of FACITPAL (14 items, score 0 to 56, higher = better quality of life)
Time frame: 1 month
Human Connection Scale (16 items, score 16 to 64, higher = more therapeutic alliance)
Dana-Farber Cancer Institute
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03244826
Neoplasms, Other Cancer
Stamford, Connecticut, United States
View Trial DetailsNCT05176860
Breast Cancer, Breast Diseases
Halifax, Nova Scotia, Canada
View Trial DetailsNCT03609177
Other Cancer
Boston, Massachusetts, United States
View Trial DetailsNCT03850912
Digestive System Diseases, Digestive System Neoplasms
Portland, Maine, United States
View Trial Details